Alemtuzumab: A Review in Relapsing Remitting Multiple Sclerosis
Yahiya Y. Syed
Topics & Concepts
AlemtuzumabTolerabilityMedicineMultiple sclerosisCD52Internal medicineRegimenRelapsing remittingInterferon beta-1aMonoclonalAdverse effectOncologyPopulationMonoclonal antibodyImmunologyAntibodyInterferon betaTransplantationEnvironmental healthMultiple Sclerosis Research StudiesImmunotherapy and Immune ResponsesRheumatoid Arthritis Research and Therapies